Choice Meds Usa Financing
Choice Meds Usa, Inc., Corporation just had published form D because of $275,000 equity financing. This is a new filing. Choice Meds Usa was able to finance itself with $25,000 so far. That is 9.09% of the round of financing. The total private offering amount was $275,000. The financing form was filed on 2016-11-30. The reason for the financing was: unspecified. The fundraising still has about $250,000 more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Choice Meds Usa is based in Alabama. The filler’s business is Pharmaceuticals. The D form was submitted by SANDEEP MATHOW DIRECTOR, PRESIDENT, SECRETARY. The company was incorporated more than five years ago. The filler’s address is: 5703 Red Bug Lake Road, Suite 256, Wintersprings, Fl, Florida, 32708. Sandeep Mathow is the related person in the form and it has address: 5703 Red Bug Lake Road, Suite 256, Wintersprings, Fl, Florida, 32708. Link to Choice Meds Usa Filing: 000114420416137141.
Analysis of Choice Meds Usa Offering
On average, firms in the Pharmaceuticals sector, sell 60.90% of the total offering amount. Choice Meds Usa sold 9.09% of the offering. The financing is still open. The average offering size for companies in the Pharmaceuticals industry is $556,000. The offering was 95.50% smaller than the average of $556,000. Of course this should not be interpreted as negative. Businesses raise funds for different reasons and needs. The minimum investment for this financing is set at $12500. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Choice Meds Usa Also
The Form D signed by SANDEEP MATHOW might help Choice Meds Usa, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.